Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
1.160
-0.510 (-30.54%)
At close: Dec 20, 2024, 4:00 PM
1.430
+0.270 (23.28%)
After-hours: Dec 20, 2024, 7:57 PM EST
Impact BioMedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 2.67 | 0 | 0 | 0.05 | 0.07 | 0.11 | Upgrade
|
| Cash & Short-Term Investments | 2.67 | 0 | 0 | 0.05 | 0.07 | 0.11 | Upgrade
|
| Cash Growth | 1227.36% | -50.00% | -95.65% | -36.42% | -33.46% | 207.37% | Upgrade
|
| Other Receivables | - | 0.13 | - | - | - | - | Upgrade
|
| Receivables | 0.14 | 0.33 | 0.02 | 0.2 | - | - | Upgrade
|
| Prepaid Expenses | 0.37 | - | 0.06 | 0 | - | - | Upgrade
|
| Other Current Assets | - | - | 0.04 | 0.04 | 0.04 | 0.03 | Upgrade
|
| Total Current Assets | 3.18 | 0.33 | 0.12 | 0.29 | 0.11 | 0.14 | Upgrade
|
| Property, Plant & Equipment | 0.28 | 0.29 | 0.28 | - | - | - | Upgrade
|
| Long-Term Investments | - | - | 0.78 | 4.82 | 0.63 | - | Upgrade
|
| Goodwill | 25.09 | 25.09 | 25.09 | 25.09 | 25.09 | - | Upgrade
|
| Other Intangible Assets | 18.09 | 18.92 | 20.03 | 21.15 | 22.26 | - | Upgrade
|
| Total Assets | 46.7 | 44.63 | 46.5 | 56.43 | 48.09 | 0.14 | Upgrade
|
| Accounts Payable | 1 | 0.83 | 0.54 | 0.12 | 0.01 | 0.01 | Upgrade
|
| Accrued Expenses | 0.1 | 0.23 | 0.06 | 0.01 | 0 | - | Upgrade
|
| Short-Term Debt | - | 12.07 | 9.99 | 12.52 | 1.06 | - | Upgrade
|
| Total Current Liabilities | 1.14 | 13.14 | 10.59 | 12.65 | 1.07 | 0.01 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.24 | 3.24 | 3.24 | 3.86 | 5.25 | - | Upgrade
|
| Total Liabilities | 12.34 | 16.37 | 13.83 | 16.5 | 6.32 | 0.01 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.07 | 0.13 | 0.13 | 0 | Upgrade
|
| Additional Paid-In Capital | 41.84 | 38.11 | 38.11 | 38.06 | 38.06 | 1.73 | Upgrade
|
| Retained Earnings | -10.56 | -12.96 | -8.63 | -1.57 | -0.27 | -1.65 | Upgrade
|
| Total Common Equity | 31.29 | 25.16 | 29.56 | 36.61 | 37.91 | 0.09 | Upgrade
|
| Minority Interest | 3 | 3.04 | 3.11 | 3.32 | 3.86 | 0.05 | Upgrade
|
| Shareholders' Equity | 34.35 | 28.26 | 32.67 | 39.92 | 41.77 | 0.13 | Upgrade
|
| Total Liabilities & Equity | 46.7 | 44.63 | 46.5 | 56.43 | 48.09 | 0.14 | Upgrade
|
| Total Debt | 8.01 | 12.07 | 9.99 | 12.52 | 1.06 | - | Upgrade
|
| Net Cash (Debt) | -5.34 | -12.07 | -9.99 | -12.48 | -0.99 | 0.11 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | 207.37% | Upgrade
|
| Net Cash Per Share | -0.09 | -0.20 | -0.14 | -0.18 | -0.01 | - | Upgrade
|
| Filing Date Shares Outstanding | 11.5 | 10 | 70.5 | 70.5 | 70.5 | - | Upgrade
|
| Total Common Shares Outstanding | 11.5 | 10 | 70.5 | 70.5 | 70.5 | - | Upgrade
|
| Working Capital | 2.04 | -12.8 | -10.47 | -12.36 | -0.96 | 0.13 | Upgrade
|
| Book Value Per Share | 2.72 | 2.52 | 0.42 | 0.52 | 0.54 | - | Upgrade
|
| Tangible Book Value | -11.89 | -18.85 | -15.57 | -9.63 | -9.44 | 0.09 | Upgrade
|
| Tangible Book Value Per Share | -1.03 | -1.89 | -0.22 | -0.14 | -0.13 | - | Upgrade
|
| Machinery | 0.03 | 0.03 | 0.03 | - | - | - | Upgrade
|
| Construction In Progress | 0.26 | 0.26 | 0.25 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.